![](/img/cover-not-exists.png)
136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1
Markus Reiser, Holger Hinrichsen, Yves Benhamou, Roel Sentjens, Heiner Wedemeyer, Luis Calleja, Xavier Forns, Jens Croenlein, Chan Yong, Gerhard Nehmiz, Gerhard SteinmannVolume:
38
Year:
2003
Language:
english
DOI:
10.1016/s0270-9139(03)80179-9
File:
PDF, 140 KB
english, 2003